Related Experiment Video

Updated: May 29, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

Protein kinase C and toll-like receptor signaling

Daniel J Loegering1, Michelle R Lennartz

  • 1Center for Cardiovascular Sciences, Albany Medical College, 47 New Scotland Avenue, Albany, NY 12208, USA.

Enzyme Research
|August 31, 2011
PubMed

Insights

Protein kinase C (PKC) activation is crucial for Toll-like receptor (TLR) signaling and the innate immune response. Specific PKC isoforms directly participate in TLR pathways, influencing cytokine secretion and downstream immune activation.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Protein kinase C (PKC) is a family of enzymes involved in various cellular processes and diseases like cancer and cardiovascular conditions.
  • Toll-like receptors (TLRs) recognize pathogens and initiate immune responses, including cytokine secretion.
  • PKC inhibitors are known to reduce lipopolysaccharide (LPS)-stimulated cytokine secretion, indicating a link between PKC and TLR signaling.

Purpose of the Study:

  • To elucidate the specific roles of Protein kinase C (PKC) isoforms in Toll-like receptor (TLR) signaling pathways.
  • To understand how PKC isoforms contribute to the innate immune response.

Main Methods:

  • Investigated the association of PKC isoforms (α, δ, ε, ζ) with TLRs and proximal receptor complex components.
  • Analyzed the involvement of these PKC isoforms in the downstream activation of key signaling molecules.

Main Results:

  • PKC-α, -δ, -ε, and -ζ isoforms were found to be directly involved in multiple stages of TLR pathways.
  • These PKC isoforms associate with TLRs or their associated receptor complex proteins.
  • PKC isoforms play a role in the activation of downstream signaling cascades including MAPK, RhoA, TAK1, and NF-κB.

Conclusions:

  • PKC activation is integral to Toll-like receptor signaling.
  • Specific PKC isoforms are critical mediators of the innate immune response through TLR pathways.

More Related Videos

A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces07:55

A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces

Published on: January 7, 2020

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...